Anne Petitjean
Queen's University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Anne Petitjean.
Journal of Organic Chemistry | 2008
Anne Petitjean; Louis A. Cuccia; Marc Schmutz; Jean-Marie Lehn
Unraveling the factors that control the conformation of molecular chains is of great interest both for understanding the shape of biological molecular strands and for designing artificial ones that adopt desired forms. Thus, a variety of artificial folding codons have been identified that enforce the formation, among others, of helices, strands, and loops, the major emphasis being on the shape of the foldamer. We report herein the synthesis and study of a family of foldamers and macrocycles based on the 1,8-naphthyridine and pyrimidine units, whose internal cavity is large enough to accommodate ionic substrates, and focus on the impact of guest binding within a cylindrical environment. Interestingly, the binding event within these large oligomers is translated to the outside of the receptors and affects the interaction of the overall complexes with the outside world. For instance, alkali cations bind to the one-turn helices and macrocycles to promote fibril formation and aggregation. Also, polyammonium substrates are able to tune the length of the overall helix assemblies and the rigidity of long oligomers. The reported data on one-turn, two-turn helices and macrocycles not only allows one to devise a model for the ion-controlled supramolecular assembly of such systems but also provides evidence that such controlled scaffolds bear promise in the design of complex systems.
Angewandte Chemie | 2009
Artur Ciesielski; Gaël Schaeffer; Anne Petitjean; Jean-Marie Lehn; Paolo Samorì
Bicomponent supramolecular polymers, consisting of two alternating molecules bridged through six H-bonds, are observed by STM at the solid-liquid interface. Control of the geometry of the 1D architecture was obtained by using two different connecting molecules with different conformational rigidity, affording either linear (see picture, left) or zigzag (right) motifs.
Journal of the American Chemical Society | 2010
Jeanne Leblond; Hui Gao; Anne Petitjean; Jean-Christophe Leroux
Molecular tweezers are dynamic devices that are able to switch from one conformation to another upon stimulation by an external trigger. In this work, we report a new water-soluble macromolecular carrier bearing a pH-responsive molecular tweezer, whose affinity for a substrate depends on the external pH. The conformational change of the switching unit was evidenced by (1)H NMR spectroscopy, and fluorescence studies conducted in aqueous media demonstrated the ability of the carrier to bind to substrates in a pH-dependent fashion.
Journal of Controlled Release | 2011
Nicolas Bertrand; Marc A. Gauthier; Céline Bouvet; Pierre Moreau; Anne Petitjean; Jean-Christophe Leroux; Jeanne Leblond
Macromolecular binders consist of polymers, dendrimers, and oligomers with binding properties for endogenous or exogenous substrates. This field, at the frontier of host/guest chemistry and pharmacology, has met a renewed interest in the past decade due to the clinical success of several sequestrants, like sevelamer hydrochloride (Renagel®) or sugammadex (Bridion®). In many instances, multivalent binding by the macromolecular drugs can modify the properties of the substrate, and may prevent it from reaching its site of action and/or trigger a biological response. From small (e.g., ions) to larger substrates (e.g., bacteria and cells), this review presents the state-of-the-art of macromolecular binders and provides detailed illustrative examples of recent developments bearing much promise for future pharmaceutical applications.
Chemical Communications | 2004
Anne Petitjean; Nathalie Kyritsakas; Jean-Marie Lehn
A novel type of 2 × 2 grid type architecture incorporating two ions of different geometries results from the single step directed self-assembly of a bischelating ligand combining bridged bidentate and tridentate complexation subunits, designed so as to lead to the ion selective and toposelective introduction of two Zn(II) and two Cu(I) cations at well-defined, diagonally located positions of, respectively, octahedral and tetrahedral coordination geometry.
Molecular Cancer Therapeutics | 2011
Patrick Merle; Bertrand Evrard; Anne Petitjean; Jean-Marie Lehn; Marie-Paule Teulade-Fichou; Emmanuel Chautard; Anne De Cian; Lionel Guittat; Phong Lan Thao Tran; Jean-Louis Mergny; Pierre Verrelle; Andrei Tchirkov
The aim of this study was to test in vitro the efficacy of TAC, an original G-quadruplex ligand, as a potential radiosensitizing agent for glioblastoma multiforme (GBM). Two human radioresistant telomerase-positive GBM cell lines (SF763 and SF767) were analyzed, with and without TAC treatment, for telomere length, cell proliferation, apoptosis, cell-cycle distribution, gene expression, cytogenetic aberrations, clonogenic survival assay, 53BP1 immunofluorescence staining, and γH2AX phosphorylation. We found that low concentrations of TAC (0.5 and 1 μmol/L) inhibited the proliferation of GBM cells in a concentration-dependent manner after only 1 week of treatment, with minimal effects on cell cycle and apoptosis. TAC treatment had no visible effect on average telomere length but modified expression levels of telomere-related genes (hTERT, TRF1, and TRF2) and induced concentration-dependent DNA damage response and dicentric chromosomes. Survival curves analysis showed that exposure to nontoxic, subapoptotic concentrations of TAC enhanced radiation-induced killing of GBM cells. Analysis of DNA repair after irradiation revealed delayed repair kinetics in GBM cells treated with TAC. Furthermore, the combined treatment (TAC and radiation) significantly increased the frequency of chromosomal aberrations as compared with radiation alone. These findings provide the first evidence that exposure to a G4 ligand radiosensitizes human glioblastoma cells and suggest the prospect of future therapeutic applications. Mol Cancer Ther; 10(10); 1784–95. ©2011 AACR.
ChemBioChem | 2015
Caitlin E. Miron; Anne Petitjean
At the cellular level, numerous processes ranging from protein folding to disease development are mediated by a sugar‐based molecular information system that is much less well known than its DNA‐ or protein‐based counterparts. The subtle structural diversity of such sugar tags nevertheless offers an excellent, if challenging, opportunity to design receptors for the selective recognition of biorelevant sugars. Over the past 40 years, growing interest in the field of sugar recognition has led to the development of several promising artificial receptors, which could soon find widespread use in medical diagnostics and cell imaging.
CrystEngComm | 2010
Anne Petitjean; Liyan Xing; Ruiyao Wang
N,N′-Dipyridylformamidine isomers crystallize differently depending on the position of the pyridyl nitrogen. The 2-pyridyl isomer self-assembles into a quadruply hydrogen-bonded dimeric macrocycle, whereas the 4-pyridyl isomer forms a hydrogen-bonded polymer. It is therefore possible to control the formation of the traditional formamidine dimer based on the positioning of basic residues.
Comptes Rendus Chimie | 2002
Anne Petitjean; Jean-Marie Lehn; Richard G. Khoury; André De Cian; Nathalie Kyritsakas
Abstract The novel ligand L1 containing two bispyridyl–naphthyridine type subunits forms a tetranuclear complex, displaying two dimetallic dirhodium sites bridged by a pyrimidine group, and presenting specific electrochemical and spectral properties.
Synthetic Communications | 2007
Liyan Xing; Anne Petitjean; Rolf Schmidt; Louis A. Cuccia
Abstract An efficient two‐step synthesis of 3,6‐diaminopyridazine from 3,6‐dichloropyridazine is reported. In this synthetic procedure, 4‐methoxybenzylamine was used as a nitrogen source to substitute the chloro groups of 3,6‐dichloropyridazine to form N,N′‐bis‐(4‐methoxybenzyl)‐pyridazine‐3,6‐diamine. The 4‐methoxybenzyl groups were then removed by treatment with hydrochloric acid to provide the target 3,6‐diaminopyridazine with an overall yield of 78%.